COUGHLIN TIMOTHY sold 5.9% of their position (3.25K shares) of TRAVERE THERAPEUTICS, INC. on the open market
Open‑market sale worth $141.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/19/2026ACC: 0001376043-26-000005
Director
Since May 2019
-3.25K
Net shares
Net seller
$141.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3.25K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3.25K
Price / share
$43.49
Trade value
$141.34K
% of position
5.9%
5/15/2026
55.50K→52.25K
Total
Net shares
−3.25K
Net value
-$141.34K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/15/2026 | S · Sale | −3.25K | $43.49 | $141.34K | 5.9% | 55.50K | 52.25K |
| Total | −3.25K | -$141.34K | ||||||
Derivative Transactions0
No derivative transactions reported